Patent · US Active

Inhibiting angiotensinogen to attenuate aortic pathology in Marfan syndrome

US11649458B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

University of Kentucky Research Foundation · US

Inventors

Alan Daugherty · Lexington, US
Hong Lu · Des Moines, US
Mary Sheppard · Lexington, US
Jeff Chen · Chiayi, TW

Key dates

Filing date	May 5, 2021
Grant date	May 16, 2023
Priority date	—
Expiry date	Jul 16, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/351
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein is a method for attenuating aortic pathology in a subject having Marfan syndrome by reducing angiotensinogen plasma levels in the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.